Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX)
- Posted on February 2, 2026
- By Yahoo News
- 2 Views
Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX)
We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. The eighth stock on our list of best biotech stocks under $20 is CytomX Therapeutics, Inc. TheFly reported on January 20 that Piper Sandler raised its price target on CTMX to $10 from $6.50, keeping an Overweight rating. The firm noted […]